A Membrane‐Targeting Aggregation‐Induced Emission Probe for Monitoring Lipid Droplet Dynamics in Ischemia/Reperfusion‐Induced Cardiomyocyte Ferroptosis
Yihui Wang,Yuan Song,Lingling Xu,Wuqi Zhou,Wenyuan Wang,Qiaofeng Jin,Yuji Xie,Junmin Zhang,Jing Liu,Wenqian Wu,He Li,Le Liang,Jing Wang,Yali Yang,Xiongwen Chen,Shuping Ge,Tang Gao,Li Zhang,Mingxing Xie
DOI: https://doi.org/10.1002/advs.202309907
IF: 15.1
2024-05-04
Advanced Science
Abstract:A a membrane‐targeting aggregation‐induced emission probe is devised to monitor lipid droplet (LD) dynamics during ischemia/reperfusion‐induced cardiomyocyte ferroptosis. These results reveals an increase in LDs during the early reperfusion stage (0–9 h), followed by degradation through lipophagy during the late reperfusion stage (>24 h). Furthermore, inhibiting LD degradation markedly mitigates myocardial ischemia/reperfusion injury in vivo by suppressing ferroptosis. Myocardial ischemia/reperfusion injury (MIRI) is the leading cause of irreversible myocardial damage. A pivotal pathogenic factor is ischemia/reperfusion (I/R)‐induced cardiomyocyte ferroptosis, marked by iron overload and lipid peroxidation. However, the impact of lipid droplet (LD) changes on I/R‐induced cardiomyocyte ferroptosis is unclear. In this study, an aggregation‐induced emission probe, TPABTBP is developed that is used for imaging dynamic changes in LD during myocardial I/R‐induced ferroptosis. TPABTBP exhibits excellent LD‐specificity, superior capability for monitoring lipophagy, and remarkable photostability. Molecular dynamics (MD) simulation and super‐resolution fluorescence imaging demonstrate that the TPABTBP is specifically localized to the phospholipid monolayer membrane of LDs. Imaging LDs in cardiomyocytes and myocardial tissue in model mice with MIRI reveals that the LD accumulation level increase in the early reperfusion stage (0–9 h) but decrease in the late reperfusion stage (>24 h) via lipophagy. The inhibition of LD breakdown significantly reduces the lipid peroxidation level in cardiomyocytes. Furthermore, it is demonstrated that chloroquine (CQ), an FDA‐approved autophagy modulator, can inhibit ferroptosis, thereby attenuating MIRI in mice. This study describes the dynamic changes in LD during myocardial ischemia injury and suggests a potential therapeutic target for early MIRI intervention.
materials science, multidisciplinary,nanoscience & nanotechnology,chemistry